Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2020 Filed Aug 4, 2020 20:50 UTC |
Lehman Gregg OwenDirector
|
SaleCommon Stock | 5,600 | $11.98 | $67,088.00 |
DisclosureSEC source: 0001014108-20-000095 · primary_doc.xml · nonDerivative · entry 1 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346 Read SEC document |
| June 30, 2020 Filed Jun 30, 2020 18:15 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
SaleCommon Stock | 400,000 | $11.00 | $4,400,000.00 |
DisclosureSEC source: 0001445866-20-000935 · primary_doc.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823,087 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. Read SEC document |
| June 29, 2020 Filed Jun 29, 2020 18:22 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
SaleCommon Stock | 20,350 | $11.87 | $241,554.50 |
DisclosureSEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,223,087 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 28, 2020 Filed Jun 29, 2020 18:22 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
SaleCommon Stock | 794 | $12.09 | $9,599.46 |
DisclosureSEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,243,437 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 18:22 UTC |
Meridian OHC Partners, LPDirector · 10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
SaleCommon Stock | 95,529 | $12.33 | $1,177,872.57 |
DisclosureSEC source: 0001445866-20-000924 · primary_doc.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001338294 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,244,231 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:08 UTC |
BlueLine Capital Partners II, L.P.Director · 10% owner
Meridian OHC LLC10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Partners, L.L.C.10% owner
|
OtherCommon Stock | 16,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-000847 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,339,760 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners II, LP. On June 11, 2020, BlueLine Capital Partners II, LP executed an in-kind distribution, without consideration, of 16,801 shares of the Issuer's common stock to certain of its limited partners. BlueLine Partners, LLC is the general partner of BlueLine Capital Partners II, LP, and Scott Shuda is managing director of BlueLine Partners, LLC. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:56 UTC |
Lehman Gregg OwenDirector
|
SaleCommon Stock | 43,083 | $10.66 | $459,264.78 |
DisclosureSEC source: 0001014108-20-000081 · primary_doc.xml · nonDerivative · entry 1 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,946 Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:57 UTC |
Steele Barry GExecutive VP and CFO
|
PurchaseCommon Stock | 1,876 | $10.59 | $19,866.84 |
DisclosureSEC source: 0001014108-20-000080 · primary_doc.xml · nonDerivative · entry 1 Steele Barry G · CIK 0001305741 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:50 UTC |
RUIZ THOMAS MARKChief Commercial Officer
|
SaleCommon Stock | 7,033 | $11.00 | $77,363.00 |
DisclosureSEC source: 0001014108-20-000079 · primary_doc.xml · nonDerivative · entry 2 RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 963 Read SEC document |
| May 22, 2020 Filed May 28, 2020 22:50 UTC |
RUIZ THOMAS MARKChief Commercial Officer
|
SaleCommon Stock | 3,516 | $11.37 | $39,976.92 |
DisclosureSEC source: 0001014108-20-000079 · primary_doc.xml · nonDerivative · entry 1 RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,996 Read SEC document |
| May 20, 2020 Filed May 22, 2020 19:05 UTC |
Sheehan JeannineChief Administrative Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000068 · primary_doc.xml · derivative · entry 1 Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning May 20, 2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:34 UTC |
Shuda ScottDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000071 · primary_doc.xml · derivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:57 UTC |
Steele Barry GExecutive VP and CFO
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000067 · primary_doc.xml · derivative · entry 1 Steele Barry G · CIK 0001305741 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning May 20, 2021. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:05 UTC |
Sansone Christopher R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000075 · primary_doc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:57 UTC |
Montgomery Darrell BDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000074 · primary_doc.xml · derivative · entry 1 Montgomery Darrell B · CIK 0001639250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:49 UTC |
GENDRON PAUL ANDREWDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000073 · primary_doc.xml · derivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:41 UTC |
Lehman Gregg OwenDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000072 · primary_doc.xml · derivative · entry 1 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:22 UTC |
Whitman KevinVP and Corporate Controller
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000070 · primary_doc.xml · derivative · entry 1 Whitman Kevin · CIK 0001768114 · VP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units will fully vest on May 20, 2023. F2 · derivative.expiration_date: These restricted stock units will fully vest on May 20, 2023. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:12 UTC |
RUIZ THOMAS MARKChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000069 · primary_doc.xml · derivative · entry 2 RUIZ THOMAS MARK · CIK 0001768484 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-20 F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F3 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning May 20, 2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:39 UTC |
Lachance CarrieExecutive VP and COO
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000066 · primary_doc.xml · derivative · entry 2 Lachance Carrie · CIK 0001790024 · Executive VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-20 F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F3 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning May 20, 2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:31 UTC |
Dilorio RichardDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000065 · primary_doc.xml · derivative · entry 2 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F2 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F3 · derivative.exercise_date: The stock option vests 33% per year on the anniversary date of the grant beginning May 20, 2021. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 19:09 UTC |
Lehman Gregg OwenDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0001014108-20-000050 · primary_doc.xml · derivative · entry 3 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2020-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 19:09 UTC |
Lehman Gregg OwenDirector
|
Tax withholdingCommon Stock | 16,917 | $12.13 | $205,203.21 |
DisclosureSEC source: 0001014108-20-000050 · primary_doc.xml · nonDerivative · entry 2 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,029 Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 19:09 UTC |
Lehman Gregg OwenDirector
|
Exercise / conversionCommon Stock | 60,000 | $3.42 | $205,200.00 |
DisclosureSEC source: 0001014108-20-000050 · primary_doc.xml · nonDerivative · entry 1 Lehman Gregg Owen · CIK 0001376620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2020 Filed Mar 31, 2020 22:03 UTC |
Shuda ScottDirector · 10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
SaleCommon Stock | 169,960 | $8.37 | $1,422,531.21 |
DisclosureSEC source: 0001445866-20-000310 · primary_doc.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote 1 Disclosed balance after: 3,356,561 F1 · ownership.direct: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were traded in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price. Imua T Capital Investments, LLC is a member of the group described in Amendment No. 1 to Schedule 13D filed by Meridian OHC Partners, LP and others on August 31, 2018. Imua T Capital Investments, LLC is managed separately from the other members of such group, and the securities reported transacting herein were all of the shares held by Imua T Capital Investments, LLC. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 17:03 UTC |
Sheehan JeannineChief Administrative Officer
|
PurchaseCommon Stock | 150 | $8.61 | $1,290.75 |
DisclosureSEC source: 0001014108-20-000048 · primary_doc.xml · nonDerivative · entry 2 Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By children Disclosed balance after: 345 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 17:03 UTC |
Sheehan JeannineChief Administrative Officer
|
PurchaseCommon Stock | 75 | $8.70 | $652.50 |
DisclosureSEC source: 0001014108-20-000048 · primary_doc.xml · nonDerivative · entry 1 Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By children Disclosed balance after: 195 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 14:40 UTC |
Sheehan JeannineChief Administrative Officer
|
PurchaseCommon Stock | 40 | $7.96 | $318.40 |
DisclosureSEC source: 0001014108-20-000046 · primary_doc.xml · nonDerivative · entry 2 Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By children Disclosed balance after: 120 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 14:40 UTC |
Sheehan JeannineChief Administrative Officer
|
PurchaseCommon Stock | 80 | $7.92 | $633.60 |
DisclosureSEC source: 0001014108-20-000046 · primary_doc.xml · nonDerivative · entry 1 Sheehan Jeannine · CIK 0001775188 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By children Disclosed balance after: 80 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 18:32 UTC |
Dilorio RichardDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $7.99 | $7,990.00 |
DisclosureSEC source: 0001014108-20-000045 · primary_doc.xml · nonDerivative · entry 1 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,689 Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 18:27 UTC |
GENDRON PAUL ANDREWDirector
|
PurchaseCommon Stock | 10,000 | $5.77 | $57,700.00 |
DisclosureSEC source: 0001014108-20-000044 · primary_doc.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to 5.99, inclusive. The Reporting Person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 18:14 UTC |
Sheehan JeannineExecutive VP and CAO
|
GrantCommon Stock | 5,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000014 · primary_doc.xml · nonDerivative · entry 1 Sheehan Jeannine · CIK 0001775188 · Executive VP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,650 F1 · kind: The reported shares were issued as part of the issuer's Short Term Incentive ("STI") plan relating to the issuer's 2019 performance. The issuer's board of directors decided that a portion of the award determined payable to the issuer's executive team would be payable in the form of fully-vested shares of the issuer's common stock. Such shares are issued under the issuer's 2014 Equity Plan. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:23 UTC |
Whitman KevinVP and Corporate Controller
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000015 · primary_doc.xml · derivative · entry 1 Whitman Kevin · CIK 0001768114 · VP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units will fully vest on December 31, 2020. F2 · derivative.expiration_date: These restricted stock units will fully vest on December 31, 2020. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:04 UTC |
RUIZ THOMAS MARKVP of Sales and Marketing
|
Tax withholdingCommon Stock | 1,937 | $8.85 | $17,142.45 |
DisclosureSEC source: 0001014108-20-000013 · primary_doc.xml · nonDerivative · entry 2 RUIZ THOMAS MARK · CIK 0001768484 · VP of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,050 F2 · kind: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on February 6, 2020. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 23:04 UTC |
RUIZ THOMAS MARKVP of Sales and Marketing
|
GrantCommon Stock | 5,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000013 · primary_doc.xml · nonDerivative · entry 1 RUIZ THOMAS MARK · CIK 0001768484 · VP of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,987 F1 · kind: The reported shares were issued as part of the issuer's Short Term Incentive ("STI") plan relating to the issuer's 2019 performance. The issuer's board of directors decided that a portion of the award determined payable to the issuer's executive team would be payable in the form of fully-vested shares of the issuer's common stock. Such shares are issued under the issuer's 2014 Equity Plan. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:58 UTC |
Lachance CarrieExecutive VP and COO
|
GrantCommon Stock | 5,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000012 · primary_doc.xml · nonDerivative · entry 1 Lachance Carrie · CIK 0001790024 · Executive VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,286 F1 · kind: The reported shares were issued as part of the issuer's Short Term Incentive ("STI") plan relating to the issuer's 2019 performance. The issuer's board of directors decided that a portion of the award determined payable to the issuer's executive team would be payable in the form of fully-vested shares of the issuer's common stock. Such shares are issued under the issuer's 2014 Equity Plan. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:52 UTC |
Dilorio RichardDirector · President and CEO
|
Tax withholdingCommon Stock | 4,125 | $8.85 | $36,506.25 |
DisclosureSEC source: 0001014108-20-000011 · primary_doc.xml · nonDerivative · entry 2 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,689 F2 · kind: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on February 6, 2020. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:52 UTC |
Dilorio RichardDirector · President and CEO
|
GrantCommon Stock | 11,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-20-000011 · primary_doc.xml · nonDerivative · entry 1 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,814 F1 · kind: The reported shares were issued as part of the issuer's Short Term Incentive ("STI") plan relating to the issuer's 2019 performance. The issuer's board of directors decided that a portion of the award determined payable to the issuer's executive team would be payable in the form of fully-vested shares of the issuer's common stock. Such shares are issued under the issuer's 2014 Equity Plan. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 20:52 UTC |
Dilorio RichardDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000171 · primary_doc.xml · derivative · entry 3 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 20:52 UTC |
Dilorio RichardDirector · President and CEO
|
Tax withholdingCommon Stock | 46,008 | $6.50 | $299,052.00 |
DisclosureSEC source: 0001014108-19-000171 · primary_doc.xml · nonDerivative · entry 2 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,514 F2 · kind: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units granted on August 23, 2018. F1 · balance_after: This total includes 1,227 shares acquired recently through the Company's Employee Stock Purchase Plan. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 20:52 UTC |
Dilorio RichardDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000171 · primary_doc.xml · nonDerivative · entry 1 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This total includes 1,227 shares acquired recently through the Company's Employee Stock Purchase Plan. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:31 UTC |
Lachance CarrieExecutive VP and COO
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000166 · primary_doc.xml · derivative · entry 1 Lachance Carrie · CIK 0001790024 · Executive VP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units will cliff vest on November 1, 2021. F2 · derivative.expiration_date: These restricted stock units will cliff vest on November 1, 2021. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:24 UTC |
RUIZ THOMAS MARKVP of Sales and Marketing
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000165 · primary_doc.xml · derivative · entry 1 RUIZ THOMAS MARK · CIK 0001768484 · VP of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units will cliff vest on November 1, 2021. F2 · derivative.expiration_date: These restricted stock units will cliff vest on November 1, 2021. Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 20:29 UTC |
Dilorio RichardDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000160 · primary_doc.xml · derivative · entry 3 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents the acquisition of Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 20:29 UTC |
Dilorio RichardDirector · President and CEO
|
Tax withholdingCommon Stock | 16,368 | $5.31 | $86,914.08 |
DisclosureSEC source: 0001014108-19-000160 · primary_doc.xml · nonDerivative · entry 2 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,295 F2 · kind: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units granted on August 23, 2018. F1 · balance_after: This total includes 1,739 shares acquired recently through the Company's Employee Stock Purchase Plan. Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 20:29 UTC |
Dilorio RichardDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-19-000160 · primary_doc.xml · nonDerivative · entry 1 Dilorio Richard · CIK 0001706994 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This total includes 1,739 shares acquired recently through the Company's Employee Stock Purchase Plan. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 20:42 UTC |
Shuda ScottDirector · 10% owner
Meridian OHC LLC10% owner
TSV Investment Partners, LLC10% owner
Meridian TSV II, LP10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Capital Partners, L.P.10% owner
|
PurchaseCommon Stock | 2,000 | $5.05 | $10,100.00 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 3 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,526,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 20:42 UTC |
Shuda ScottDirector · 10% owner
Meridian OHC LLC10% owner
TSV Investment Partners, LLC10% owner
Meridian TSV II, LP10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Capital Partners, L.P.10% owner
|
PurchaseCommon Stock | 2,000 | $5.00 | $10,000.00 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 2 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 20:42 UTC |
Shuda ScottDirector · 10% owner
Meridian OHC LLC10% owner
TSV Investment Partners, LLC10% owner
Meridian TSV II, LP10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Capital Partners, L.P.10% owner
|
PurchaseCommon Stock | 1,004 | $4.90 | $4,919.60 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,522,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 19:46 UTC |
Sansone Christopher R.Director
|
PurchaseCommon Stock | 1,716 | $4.95 | $8,495.74 |
DisclosureSEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 308,118 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.